{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T18:41:54Z","timestamp":1732041714112},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-022-03141-5","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T04:08:48Z","timestamp":1658722128000},"page":"461-468","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study"],"prefix":"10.1007","volume":"77","author":[{"given":"Ravindran","family":"Ragavi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prashant Shankarrao","family":"Adole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kolar Vishwanath","family":"Vinod","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajith Ananthakrishna","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"3141_CR1","doi-asserted-by":"publisher","first-page":"1478294","DOI":"10.1155\/2017\/1478294","volume":"2017","author":"JF Ndisang","year":"2017","unstructured":"J.F. Ndisang, A. Vannacci, S. Rastogi, Insulin resistance, type 1 and type 2 diabetes, and related complications 2017. J. Diabetes Res. 2017, 1478294 (2017)","journal-title":"J. Diabetes Res."},{"key":"3141_CR2","doi-asserted-by":"publisher","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","volume":"157","author":"P Saeedi","year":"2019","unstructured":"P. Saeedi, I. Petersohn, P. Salpea, B. Malanda, S. Karuranga, N. Unwin et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res. Clin. Pract. 157, 107843 (2019)","journal-title":"Diabetes Res. Clin. Pract."},{"key":"3141_CR3","first-page":"e1352","volume":"6","author":"N Tandon","year":"2018","unstructured":"N. Tandon, R.M. Anjana, V. Mohan, T. Kaur, A. Afshin, K. Ong et al. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990\u20132016. Lancet. Glob. Health 6, e1352\u2013e1362 (2018)","journal-title":"Glob. Health"},{"issue":"2","key":"3141_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2174\/1570161117666190502103733","volume":"18","author":"C Faselis","year":"2020","unstructured":"C. Faselis, A. Katsimardou, K. Imprialos, P. Deligkaris, M. Kallistratos, K. Dimitriadis, Microvascular complications of type 2 diabetes mellitus. Curr. Vasc. Pharm. 18(2), 117\u2013124 (2020)","journal-title":"Curr. Vasc. Pharm."},{"issue":"3","key":"3141_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.21037\/cdt.2016.03.05","volume":"6","author":"S Deora","year":"2016","unstructured":"S. Deora, T. Kumar, R. Ramalingam, C.N. Manjunath, Demographic and angiographic profile in premature cases of acute coronary syndrome: analysis of 820 young patients from South India. Cardiovasc. Diagn. Ther. 6(3), 193\u2013198 (2016)","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"6","key":"3141_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nrendo.2016.53","volume":"12","author":"R Unnikrishnan","year":"2016","unstructured":"R. Unnikrishnan, R.M. Anjana, V. Mohan, Diabetes mellitus and its complications in India. Nat. Rev. Endocrinol. 12(6), 357\u2013370 (2016)","journal-title":"Nat. Rev. Endocrinol."},{"issue":"3","key":"3141_CR7","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.15419\/bmrat.v8i3.663","volume":"8","author":"FO Ohiagu","year":"2021","unstructured":"F.O. Ohiagu, P.C. Chikezie, C.M. Chikezie, Pathophysiology of diabetes mellitus complications: Metabolic events and control. Biomed. Res. Ther. 8(3), 4243\u20134257 (2021)","journal-title":"Biomed. Res. Ther."},{"key":"3141_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.cca.2021.06.002","volume":"520","author":"S Bora","year":"2021","unstructured":"S. Bora, P.S. Adole, Carbonyl stress in diabetics with acute coronary syndrome. Clin. Chim. Acta 520, 78\u201386 (2021)","journal-title":"Clin. Chim. Acta"},{"issue":"1","key":"3141_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s10020-018-0060-3","volume":"24","author":"SL Fishman","year":"2018","unstructured":"S.L. Fishman, H. Sonmez, C. Basman, V. Singh, L. Poretsky, The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review. Mol. Med. 24(1), 59 (2018)","journal-title":"Mol. Med."},{"key":"3141_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3389\/fcvm.2020.00037","volume":"7","author":"L Ega\u00f1a-Gorro\u00f1o","year":"2020","unstructured":"L. Ega\u00f1a-Gorro\u00f1o, R. L\u00f3pez-D\u00edez, G. Yepuri, L.S. Ramirez, S. Reverdatto, P.F. Gugger et al. Receptor for advanced glycation end products (RAGE) and mechanisms and therapeutic opportunities in diabetes and cardiovascular disease: insights from human subjects and animal models. Front. Cardiovasc. Med. 7, 37 (2020)","journal-title":"Front. Cardiovasc. Med."},{"issue":"2","key":"3141_CR11","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/1753-0407.12475","volume":"9","author":"SI Yamagishi","year":"2017","unstructured":"S.I. Yamagishi, N. Nakamura, T. Matsui, Glycation and cardiovascular disease in diabetes: a perspective on the concept of metabolic memory. J. Diabetes 9(2), 141\u2013148 (2017)","journal-title":"J. Diabetes"},{"key":"3141_CR12","doi-asserted-by":"publisher","first-page":"101958","DOI":"10.1016\/j.redox.2021.101958","volume":"42","author":"JD Erusalimsky","year":"2021","unstructured":"J.D. Erusalimsky, The use of the soluble receptor for advanced glycation-end products (sRAGE) as a potential biomarker of disease risk and adverse outcomes. Redox Biol. 42, 101958 (2021)","journal-title":"Redox Biol."},{"issue":"10","key":"3141_CR13","doi-asserted-by":"publisher","first-page":"3716","DOI":"10.1096\/fj.08-109033","volume":"22","author":"A Raucci","year":"2008","unstructured":"A. Raucci, S. Cugusi, A. Antonelli, S.M. Barabino, L. Monti, A. Bierhaus et al. A soluble form of the receptor for advanced glycation end products (RAGE) is produced by proteolytic cleavage of the membrane\u2010bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10). FASEB J. 22(10), 3716\u20133727 (2008)","journal-title":"FASEB J."},{"issue":"9","key":"3141_CR14","doi-asserted-by":"publisher","first-page":"e0137330","DOI":"10.1371\/journal.pone.0137330","volume":"10","author":"AC Lee","year":"2015","unstructured":"A.C. Lee, J.K. Lam, S.W. Shiu, Y. Wong, D.J. Betteridge, K.C. Tan, Serum level of soluble receptor for advanced glycation end products is associated with a disintegrin and metalloproteinase 10 in type 1 diabetes. PLoS One 10(9), e0137330 (2015)","journal-title":"PLoS One"},{"key":"3141_CR15","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3389\/fgene.2018.00540","volume":"9","author":"WH Huang","year":"2018","unstructured":"W.H. Huang, W. Chen, L. Jiang, Y.X. Yang, L.F. Yao, K.S. Li, Influence of ADAM10 polymorphisms on plasma level of soluble receptor for advanced glycation end products and the association with Alzheimer\u2019s disease risk. Front. Genet. 9, 540 (2018)","journal-title":"Front. Genet."},{"issue":"12","key":"3141_CR16","first-page":"BC07","volume":"10","author":"AJ Sathyaseelan","year":"2016","unstructured":"A.J. Sathyaseelan, P.S. Adole, M. Wyawahare, R.P. Saya, Assessment of serum VASPIN levels among type 2 diabetes mellitus patients with or without acute coronary syndrome. J. Clin. Diagn. Res 10(12), BC07\u2013BC10 (2016)","journal-title":"J. Clin. Diagn. Res"},{"key":"3141_CR17","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1007\/s12020-014-0427-3","volume":"48","author":"J Yang","year":"2015","unstructured":"J. Yang, L. Li, D. Raptis, X. Li, F. Li, B. Chen et al. Pancreatic stone protein\/regenerating protein (PSP\/reg): a novel secreted protein up-regulated in type 2 diabetes mellitus. Endocrine 48, 856\u2013862 (2015)","journal-title":"Endocrine"},{"key":"3141_CR18","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.annepidem.2021.02.016","volume":"58","author":"P Ranasinghe","year":"2021","unstructured":"P. Ranasinghe, R. Jayawardena, N. Gamage, N. Sivanandam, A. Misra, Prevalence and trends of the diabetes epidemic in urban and rural India: A pooled systematic review and meta-analysis of 1.7 million adults. Ann. Epidemiol. 58, 128\u2013148 (2021)","journal-title":"Ann. Epidemiol."},{"key":"3141_CR19","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12933-020-01170-w","volume":"19","author":"SJ Park","year":"2020","unstructured":"S.J. Park, K.H. Ha, D.J. Kim, Body mass index and cardiovascular outcomes in patients with acute coronary syndrome by diabetes status: the obesity paradox in a Korean national cohort study. Cardiovasc. Diabetol. 19, 191 (2020)","journal-title":"Cardiovasc. Diabetol."},{"issue":"6","key":"3141_CR20","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1002\/jcsm.12471","volume":"10","author":"JT Niedziela","year":"2019","unstructured":"J.T. Niedziela, B. Hudzik, K. Strojek, L. Polo\u0144ski, M. G\u0105sior, P. Rozentryt, Weight loss in heart failure is associated with increased mortality only in non-obese patients without diabetes. J. Cachexia Sarcopenia Muscle 10(6), 1307\u20131315 (2019)","journal-title":"J. Cachexia Sarcopenia Muscle"},{"issue":"3","key":"3141_CR21","first-page":"e4265","volume":"11","author":"N Kumar","year":"2019","unstructured":"N. Kumar, S. Kumar, A. Kumar, T. Shakoor, A. Rizwan, Lipid profile of patients with acute myocardial infarction (AMI). Cureus 11(3), e4265 (2019)","journal-title":"Cureus"},{"key":"3141_CR22","first-page":"517","volume":"14","author":"AK Shrivastava","year":"2015","unstructured":"A.K. Shrivastava, H.V. Singh, A. Raizada, S.K. Singh, Serial measurement of lipid profile and inflammatory markers in patients with acute myocardial infarction. EXCLI J. 14, 517\u2013526 (2015)","journal-title":"EXCLI J."},{"issue":"3","key":"3141_CR23","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ihj.2015.09.026","volume":"68","author":"F Ali","year":"2016","unstructured":"F. Ali, S.A. Naqvi, M. Bismillah, N. Wajid, Comparative analysis of biochemical parameters in diabetic and non-diabetic acute myocardial infarction patients. Indian Heart J. 68(3), 325\u2013331 (2016)","journal-title":"Indian Heart J."},{"key":"3141_CR24","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12933-020-01068-7","volume":"19","author":"M Kopytek","year":"2020","unstructured":"M. Kopytek, M. Z\u0105bczyk, P. Mazur, A. Undas, J. Natorska, Accumulation of advanced glycation end products (AGEs) is associated with the severity of aortic stenosis in patients with concomitant type 2 diabetes. Cardiovasc. Diabetol. 19, 92 (2020)","journal-title":"Cardiovasc. Diabetol."},{"issue":"01","key":"3141_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1055\/s-0040-1721813","volume":"30","author":"K Prasad","year":"2021","unstructured":"K. Prasad, AGE\u2013RAGE stress and coronary artery disease. Int. J. Angiol. 30(01), 4\u201314 (2021)","journal-title":"Int. J. Angiol."},{"issue":"2","key":"3141_CR26","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.atherosclerosis.2013.01.016","volume":"227","author":"K Fujisawa","year":"2013","unstructured":"K. Fujisawa, N. Katakami, H. Kaneto, T. Naka, M. Takahara, F. Sakamoto et al. Circulating soluble RAGE as a predictive biomarker of cardiovascular event risk in patients with type 2 diabetes. Atherosclerosis 227(2), 425\u2013428 (2013)","journal-title":"Atherosclerosis"},{"key":"3141_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/s11010-018-3400-2","volume":"451","author":"K Prasad","year":"2019","unstructured":"K. Prasad, Is there any evidence that AGE\/sRAGE is a universal biomarker\/risk marker for diseases? Mol. Cell. Biochem. 451, 139\u2013144 (2019)","journal-title":"Mol. Cell. Biochem."},{"key":"3141_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2017.07.008","volume":"264","author":"SG Wannamethee","year":"2017","unstructured":"S.G. Wannamethee, P. Welsh, O. Papacosta, S.A. Ellin, J.P.J. Halcox, P.H. Whincup et al. Circulating soluble receptor for advanced glycation end product: Cross-sectional associations with cardiac markers and subclinical vascular disease in older men with and without diabetes. Atherosclerosis 264, 36\u201343 (2017)","journal-title":"Atherosclerosis"},{"issue":"2","key":"3141_CR29","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1590\/S1676-24442013000200004","volume":"49","author":"MIA Oliveira","year":"2013","unstructured":"M.I.A. Oliveira, E.M. de Souza, F.O. Pedrosa, R.R. Rea, A. de Silva Couto Alves, G. Picheth et al. RAGE receptor and its soluble isoforms in diabetes mellitus complications. J. Bras. Patol. Med. Lab 49(2), 97\u2013108 (2013)","journal-title":"J. Bras. Patol. Med. Lab"},{"issue":"2","key":"3141_CR30","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1042\/CS20100256","volume":"120","author":"XM Tam","year":"2011","unstructured":"X.M. Tam, S.W. Shiu, L. Leng, R. Bucala, D.J. Betteridge, K.C. Tan, Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in type 2 diabetes. Clin. Sci. 120(2), 81\u201389 (2011)","journal-title":"Clin. Sci."},{"issue":"4","key":"3141_CR31","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.diabet.2008.04.003","volume":"34","author":"N Grossin","year":"2008","unstructured":"N. Grossin, M.P. Wautier, T. Meas, P.J. Guillausseau, P. Massin, J.L. Wautier, Severity of diabetic microvascular complications is associated with a low soluble RAGE level. Diabetes Metab. 34(4), 392\u2013395 (2008)","journal-title":"Diabetes Metab."},{"issue":"5","key":"3141_CR32","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","volume":"25","author":"C Falcone","year":"2005","unstructured":"C. Falcone, E. Emanuele, A. D\u2019Angelo, M.P. Buzzi, C. Belvito, M. Cuccia et al. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler. Thromb. Vasc. Biol. 25(5), 1032\u20131037 (2005)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"10","key":"3141_CR33","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.1016\/j.jstrokecerebrovasdis.2014.05.037","volume":"23","author":"S Moriya","year":"2014","unstructured":"S. Moriya, M. Yamazaki, H. Murakami, K. Maruyama, S. Uchiyama, Two soluble isoforms of receptors for advanced glycation end products (RAGE) in carotid atherosclerosis: the difference of soluble and endogenous secretory RAGE. J. Stroke Cerebrovasc. Dis. 23(10), 2540\u20132546 (2014)","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"10","key":"3141_CR34","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.7150\/ijbs.56379","volume":"17","author":"F Scavello","year":"2021","unstructured":"F. Scavello, F. Zeni, G. Milano, F. Macri, S. Castiglione, E. Zuccolo et al. Soluble receptor for advanced glycation end-products regulates age-associated cardiac fibrosis. Int. J. Biol. Sci. 17(10), 2399\u20132416 (2021)","journal-title":"Int. J. Biol. Sci."},{"issue":"5","key":"3141_CR35","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1161\/ATVBAHA.118.312319","volume":"39","author":"HG Larsen","year":"2019","unstructured":"H.G. Larsen, G. Marinkovic, P.M. Nilsson, J. Nilsson, G. Engstr\u00f6m, O. Melander et al. High plasma sRAGE (soluble receptor for advanced glycation end products) is associated with slower carotid intima-media thickness progression and lower risk for first-time coronary events and mortality. Arterioscler. Thromb. Vasc. Biol. 39(5), 925\u2013933 (2019)","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"3141_CR36","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.redox.2013.12.016","volume":"2","author":"C Ott","year":"2014","unstructured":"C. Ott, K. Jacobs, E. Haucke, A. Navarrete Santos, T. Grune, A. Simm, Role of advanced glycation end products in cellular signalling. Redox Biol. 2, 411\u2013429 (2014)","journal-title":"Redox Biol."},{"key":"3141_CR37","doi-asserted-by":"publisher","first-page":"e4421","DOI":"10.7717\/peerj.4421","volume":"6","author":"FN Wong","year":"2018","unstructured":"F.N. Wong, K.H. Chua, J.A.M.A. Tan, C.M. Wong, U.R. Kuppusamy, Glycaemic control in type 2 diabetic patients with chronic kidney disease: the impacts on enzymatic antioxidants and soluble RAGE. Peer J. 6, e4421 (2018)","journal-title":"Peer J."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03141-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-022-03141-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-022-03141-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,17]],"date-time":"2022-08-17T15:33:45Z","timestamp":1660750425000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-022-03141-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["3141"],"URL":"https:\/\/doi.org\/10.1007\/s12020-022-03141-5","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"assertion":[{"value":"26 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Written informed consent was obtained from all participants for the publication of any potentially identifiable images or data included in this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All procedures followed were as per the ethical standards of the responsible committee on human experimentation (institutional and national), and with the Helsinki Declaration of 1964, as revised in 2013. This study was approved by the institutional ethics committee for human studies (JIP\/IEC\/2019\/0155 dated June 24, 2019).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all individual participants included in the study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}